Logo

Biocrates Raises $6.3M to Commercialize High-Content Products

Jun 29, 2006

NEW YORK, June 29 (GenomeWeb News) - Biocrates Life Sciences said today that it has closed a €5 million ($6.3 million) private equity investment with MIG Funds of Germany.

 

The financing will enable Biocrates to commercialize its high-content metabolite analysis platform, application software, and consumable-based products.

 

The MIG corporations raise venture capital to invest preferentially into selected businesses in Germany and Austria.

Breaking News
The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.